Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05786547 · ClinicalTrials.gov registry record · Phase 3

V+PSF-M for Tobacco Cessation in HIV Care in India

A Phase 3 study of Smoking Cessation and Human Immunodeficiency Virus, sponsored by University of Colorado, Denver.

Recruiting
Registry status
Phase 3
Development phase
400
Enrollment target
2
Study locations

NCT05786547 is a Phase 3 study of Smoking Cessation and Human Immunodeficiency Virus that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 400 participants, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (15% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05786547, a Phase 3 study of Smoking Cessation and Human Immunodeficiency Virus, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
Phase 3
Development phase
400 participants
Enrollment target
2
Study locations

Study Summary

The goal of this research study is to test an intervention to help quit tobacco use in participants with Human Immunodeficiency Virus (HIV). The study interventions used in this research study are: * Positively Smoke Free - Mobile (PSF-M) (mobile behavioral program) * Varenicline (or Chantix, apovarenicline, Champix or Nocrav)

Conditions Studied

Smoking Cessation Human Immunodeficiency Virus Smoking, Tobacco

Interventions

  • DRUG Varenicline
  • BEHAVIORAL Standard Care
  • BEHAVIORAL Positively Smoke Free Mobile (PSF-M)

Study Locations (2)

Colorado

  • University of Colorado - Aurora

Tamil Nadu

  • VHS Infectious Disease Medical Centre, CART Clinical Research Site - Chennai

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2024-01-02
Est. Completion 2026-07-22
Phase Phase 3

Sponsor

University of Colorado, Denver

1,283 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05786547

The ClinicalTrials.gov registry entry for NCT05786547 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (15% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 3 interventions - of which Varenicline is the first listed.

NCT05786547 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Colorado, Tamil Nadu.

Frequently Asked Questions

What is clinical trial NCT05786547 about?

NCT05786547 is a clinical study titled "V+PSF-M for Tobacco Cessation in HIV Care in India". The goal of this research study is to test an intervention to help quit tobacco use in participants with Human Immunodeficiency Virus (HIV). The study interventions used in this research study are: * Positively Smoke Free - Mobile (PSF-M) (mobile behavioral program) * Varenicline (or Chantix, apov...

What is the current status of trial NCT05786547?

This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 400 participants. The study started on 2024-01-02. Estimated completion is 2026-07-22.

What conditions does trial NCT05786547 study?

This clinical trial studies the following conditions: Smoking Cessation, Human Immunodeficiency Virus, Smoking, Tobacco.

What interventions are being tested in trial NCT05786547?

The interventions under investigation include: Varenicline (DRUG), Standard Care (BEHAVIORAL), Positively Smoke Free Mobile (PSF-M) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05786547?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05786547 being conducted?

This trial has 2 study locations across Colorado, Tamil Nadu. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Smoking Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Smoking Cessation

All registered trials for this condition

Human Immunodeficiency Virus

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.